Lb Pharmaceuticals (LBRX) Shares Outstanding (2024 - 2026)

Lb Pharmaceuticals' Shares Outstanding (Entity) history runs 3 years deep, the most recent figure standing at $28.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 7892.38% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $28.7 million (up 7892.38% YoY), while the FY2025 annual figure was $8.0 million, up 2145.81% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $28.7 million, up from $8.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $28.7 million in Q1 2026, with the low at $358229.0 in Q4 2024.
• The 3-year median for Shares Outstanding (Entity) is $3.1 million (2024), against an average of $7.3 million.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) surged 1517.15% in 2025, then surged 7892.38% in 2026.
• Lb Pharmaceuticals' Shares Outstanding (Entity) stood at $358229.0 in 2024, then jumped by 2145.81% to $8.0 million in 2025, then surged by 256.42% to $28.7 million in 2026.
• Business Quant data shows LBRX's Shares Outstanding (Entity) at $28.7 million in Q1 2026, $8.0 million in Q4 2025, and $5.8 million in Q3 2025.